Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
?

?

9.740%
0.09
9.740%
-

-

 
08:20 / Frankfurt WKN: A2DS5F / Name: Valbiotis / Stock / Biotechnology & Medical Research / Micro Cap /
Your prediction

Valbiotis Stock

A very strong showing by Valbiotis today, with an increase of €0.090 (9.740%) compared to yesterday's price.
So far the community has only identified positive things for Valbiotis stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Valbiotis in the next few years

Pros
?
S********** s********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Valbiotis vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Valbiotis 9.740% - - - - - -
Sensorion SA -33.820% -6.079% 95.570% - - - -
Cerenis Therapeutics Holding S.A. -1.450% -3.120% -6.193% 150.808% -9.475% 46.118% 237.867%
Genoway S.A. Inh. 0.880% 1.339% -2.575% -31.212% -8.468% -36.503% -37.637%

News

VALBIOTIS SA: Valbiotis announces launch of operations in Asia
VALBIOTIS SA: Valbiotis announces launch of operations in Asia
VALBIOTIS SA: Valbiotis announces launch of operations in Asia
VALBIOTIS SA: Valbiotis raises awareness of cardiometabolic risks with the Cœur en Jeu prevention campaign
VALBIOTIS SA: Valbiotis raises awareness of cardiometabolic risks with the Cœur en Jeu prevention campaign
VALBIOTIS SA: Valbiotis raises awareness of cardiometabolic risks with the Cœur en Jeu prevention campaign
VALBIOTIS SA: 2025 Financial Results
VALBIOTIS SA: 2025 Financial Results
VALBIOTIS SA: 2025 Financial Results